Skip to main content
Premium Trial:

Request an Annual Quote

Lunaphore, Indica Labs Partner on Spatial Biology Workflows

NEW YORK – Lunaphore and Indica Labs announced on Thursday a partnership to provide a complete workflow for spatial biology and tissue image analysis.

Under the agreement, the two companies will comarket a system that combines Lausanne, Switzerland-based Lunaphore's Comet spatial biology platform and Albuquerque, New Mexico-based Indica's Halo and Halo AI digital pathology image analysis software.

Lunaphore's Comet system allows for automated detection of up to 40 different spatial markers per tissue slide while Indica's software provides tools for quantifying markers in tissue and developing deep learning classifiers that can be used to investigate relationships between marker expression and spatial distribution and cell phenotypes.

"Our partnership with Indica Labs is another key aspect of our strategy to combine our Comet technology with industry-leading image analysis technologies," Deborah Heintze, chief marketing officer of Lunaphore, said in a statement. "Indica Labs' solutions are used by a large set of researchers in the field, thanks to their ease of use and analysis capabilities. Combining Indica's solutions with the class-leading capabilities of Comet will help us pursue our shared goal of making tissue image analysis easier and more accessible to labs around the world."

Financial and other terms of the agreement were not disclosed.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.